ATE425751T1 - Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel - Google Patents

Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel

Info

Publication number
ATE425751T1
ATE425751T1 AT05712747T AT05712747T ATE425751T1 AT E425751 T1 ATE425751 T1 AT E425751T1 AT 05712747 T AT05712747 T AT 05712747T AT 05712747 T AT05712747 T AT 05712747T AT E425751 T1 ATE425751 T1 AT E425751T1
Authority
AT
Austria
Prior art keywords
closantel
organic amine
amine salt
composition containing
antiparasitic composition
Prior art date
Application number
AT05712747T
Other languages
English (en)
Inventor
Robert Albright
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE425751T1 publication Critical patent/ATE425751T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT05712747T 2004-02-02 2005-01-28 Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel ATE425751T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54116204P 2004-02-02 2004-02-02

Publications (1)

Publication Number Publication Date
ATE425751T1 true ATE425751T1 (de) 2009-04-15

Family

ID=34837467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05712747T ATE425751T1 (de) 2004-02-02 2005-01-28 Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel

Country Status (11)

Country Link
US (1) US7666444B2 (de)
EP (2) EP1713466B1 (de)
AT (1) ATE425751T1 (de)
AU (1) AU2005210660A1 (de)
BR (1) BRPI0507333A (de)
CA (1) CA2553039A1 (de)
DE (1) DE602005013360D1 (de)
ES (1) ES2323137T3 (de)
MX (1) MXPA06008751A (de)
NZ (1) NZ548689A (de)
WO (1) WO2005074912A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
CA2706448C (en) * 2007-11-26 2016-08-16 Merial Limited Solvent systems for pour-on formulations for combating parasites
AU2013201461B2 (en) * 2007-11-26 2015-10-29 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
WO2010106325A2 (en) 2009-03-18 2010-09-23 Omnipharm Limited Parasiticidal formulation
GB201021836D0 (en) * 2010-12-21 2011-02-02 Norbrook Lab Ltd Topical Composition
EP3338783B1 (de) 2014-09-12 2024-01-24 UNION therapeutics A/S Antibakterielle verwendung halogenierter salicylanilide
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
UY40429A (es) 2016-02-24 2023-10-13 Boehringer Ingelheim Animal Health Usa Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN110279657B (zh) * 2019-07-29 2021-07-27 河南官渡生物工程有限公司 一种氯氰碘柳胺钠注射液及其制备方法
EP3815677B1 (de) 2019-10-30 2023-08-30 KRKA, d.d., Novo mesto Stabile veterinärmedizinische zusammensetzung mit moxidectin und imidacloprid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005218A (en) 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US5169846A (en) 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
DE69432985D1 (de) 1993-06-15 2003-09-04 Australian Nat University Acto Synergistische anthelmintische zusammensetzungen gegen fasciola hepatica und andere fascola spezien
NZ248486A (en) 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AUPQ875700A0 (en) 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
CN1375287A (zh) 2001-03-16 2002-10-23 王玉万 含氯氰碘柳胺或其钠盐的兽用混悬注射剂
EP1476121A4 (de) 2002-02-08 2010-10-27 Merck Sharp & Dohme Topische ivermectin-zusammensetzung
GB2386067A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
FR2839614B1 (fr) 2002-05-14 2004-08-13 Virbac Sa Nouvelles compositions orales huileuses antiparasitaires
US6653288B1 (en) 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
AU2002952597A0 (en) 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
WO2004047803A1 (fr) 2002-11-27 2004-06-10 Eco Animal Health Ltd Injection de medicament pour animaux renfermant du closantel ou du sodium de closantel
BRPI0409185B1 (pt) 2003-04-04 2018-05-15 Merial, Inc Formulações veterinárias anti-helmínticas tópicas

Also Published As

Publication number Publication date
EP1713466B1 (de) 2009-03-18
BRPI0507333A (pt) 2007-07-03
EP1713466A2 (de) 2006-10-25
WO2005074912A2 (en) 2005-08-18
CA2553039A1 (en) 2005-08-18
AU2005210660A1 (en) 2005-08-18
WO2005074912A3 (en) 2006-04-20
NZ548689A (en) 2010-06-25
DE602005013360D1 (de) 2009-04-30
US20050197302A1 (en) 2005-09-08
ES2323137T3 (es) 2009-07-07
US7666444B2 (en) 2010-02-23
EP2065042A3 (de) 2009-07-22
MXPA06008751A (es) 2007-01-19
EP2065042A2 (de) 2009-06-03

Similar Documents

Publication Publication Date Title
AR057914A1 (es) Compuestos organicos de azufre y su uso
ATE425751T1 (de) Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel
EA201070881A1 (ru) Полихромные вещества и их применение
EP1720802A4 (de) Oxidation von organischen verbindungen bei hohem ph
EA200701121A1 (ru) Потенциаторы рецепторов глутамата
EP2502908A4 (de) Aromatisches aminderivat und organisches elektrolumineszenzelement damit
ATE513842T1 (de) Neue dihydropseudoerythromycinderivate
BRPI0512516A (pt) composto ou um sal, enanciÈmero, racemato, diastereÈmero ou mistura de diastereÈmeros farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
DE602005007488D1 (de) Zusammensetzung mit interkalierten funktionell aktiven organischen verbindungen
GB0521508D0 (en) Organic compounds
DE602004005888D1 (de) Herstellung von selbstorganisierten monoschichten
DE602008005606D1 (de) Kautschukzusammensetzungen
ATE550013T1 (de) Zink-konservierungszusammensetzung und anwendungsverfahren
ECSP077130A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos
EP2237035A3 (de) Taxolderivaten für Taxol-Immunoassay
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
ATE382609T1 (de) Malononitrilverbindungen als pestizide
EA200701476A1 (ru) Новые гетероциклические соединения оксима, способ их получения и фармацевтические композиции, которые их содержат
GT200200250A (es) Compuestos hexaciclicos
ATE425948T1 (de) Substituierte hydroxyacetophenonderivative
DK1805203T3 (da) Peptid-cyklisering på harpiks
ITRM20030381A1 (it) Composti polimerici pirrolici, in particolare per
BRPI0519680A2 (pt) compostos orgÂnicos
AR072038A1 (es) Ciclopropancarboxilato y composicion de control de plagas que lo contienen
ATE476181T1 (de) Neues arylamid-derivat, salz davon und diese enthaltendes antimykotisches mittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties